OPKO Health Inc (NASDAQ:OPK)
| 2.52 Delayed Data As of Aug 12 |  +0.02 / +0.80%Today’s Change | 2.15 Today|||52-Week Range 5.25 | -47.61% Year-to-Date |
Latest OPK News | Press Releases
| Why Opko Health Stock Was a Surprise Winner This Week Aug 11 / MotleyFool.com - Paid Partner Content | Opko Health (OPK) Q2 2022 Earnings Call Transcript Aug 05 / MotleyFool.com - Paid Partner Content |
| OPKO Health (OPK) Stock Gains 2.1% Despite Q2 Earnings Miss Aug 09 / Zacks.com - Paid Partner Content | OPKO Health (OPK) Reports Q2 Loss, Lags Revenue Estimates Aug 04 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 2.50 |
| Today’s open | 2.52 |
| Day’s range | 2.45 - 2.54 |
| Volume | 129,317 |
| Average volume (3 months) | 4,232,356 |
| Market cap | $1.9B |
Data as of 4:00pm ET, 08/12/2022
Growth & Valuation
| Earnings growth (last year) | -197.48% |
| Earnings growth (this year) | -664.00% |
| Earnings growth (next 5 years) | +12.00% |
| Revenue growth (last year) | +23.64% |
| P/E ratio | NM |
| Price/Sales | 1.76 |
| Price/Book | 1.01 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Almirall SA | 0.00 | 0.00% |
| ---- | ||
| KRYSKrystal Biotech Inc | +5.75 | +7.83% |
| ---- |
Data as of 3:59pm ET, 08/12/2022
Financials
| Next reporting date | October 27, 2022 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $1.8B |
| Annual profit (last year) | -$30.1M |
| Net profit margin | -1.70% |
Profile
Sector Health Services |
Industry Medical/Nursing Services |
No executives to display |
Corporate headquarters Miami, Florida |
Forecasts
